Exagen OverviewExagen EBIT
EBIT (Earnings Before Interest and Taxes) analysis for XGN.
Quarterly EBIT
-$3.41M
↓ 1.46% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$10.96M
↑ 20.59% YoY
Trailing 12 months ending Mar 31, 2026
Exagen OverviewEBIT (Earnings Before Interest and Taxes) analysis for XGN.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026